Geoffrey Nichol

Filings by Geoffrey Nichol span 2 companies, the busiest being Sangamo Therapeutics, Inc and Medarex Inc. Over a trading history stretching from 24 February 2009 to 12 December 2015, the count stands at 13 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 15 December 2015, reports a share grant of €37k in Sangamo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.